Suzy Jones was previously Head of Business Development @ Genetech prior to it's aquisition by Roche for $45B in 2009, don't forget Genetech was a company twice the size of CSL.
So why would Suzy Jones previously the head of business development at a multi billion dollar pharmaceutical company come here? with a micro cap of $11M but a portfolio of novel human antibody treatments for cancer entering clinical trials & setting up to be outlicensed.
I highly doubt she came because the science sucked
Make up your own minds.
- Forums
- ASX - By Stock
- PAB
- the demise of csl
the demise of csl, page-8
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $326 | 49.40K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1134114 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1355403 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1134114 | 0.006 |
14 | 7550157 | 0.005 |
10 | 5864000 | 0.004 |
5 | 5899016 | 0.003 |
1 | 2520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1355403 | 3 |
0.008 | 2061233 | 5 |
0.010 | 1396000 | 6 |
0.011 | 680000 | 2 |
0.012 | 292407 | 2 |
Last trade - 10.29am 28/08/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online